{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:41:10Z","timestamp":1793374870663,"version":"4.5.0"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"1160","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diuretic-induced hypokalaemia is a common and potentially life-threatening adverse drug reaction in clinical practice. Previous studies revealed a prevalence of 7%\u201356% of hypokalaemia in patients taking thiazide diuretics. The clinical manifestations of hypokalaemia due to diuretics are non-specific, varying from asymptomatic to fatal arrhythmia. Diagnosis of hypokalaemia is based on the level of serum potassium. ECG is useful in identifying the more severe consequences. A high dosage of diuretics and concomitant use of other drugs that increase the risk of potassium depletion or cardiac arrhythmias can increase the risk of cardiovascular events and mortality. Thiazide-induced potassium depletion may cause dysglycaemia. The risk of thiazide-induced hypokalaemia is higher in women and in black people. Reducing diuretic dose and potassium supplementation are the most direct and effective therapies for hypokalaemia. Combining with a potassium-sparing diuretic or blocker of the renin\u2013angiotensin system also reduces the risk of hypokalaemia. Lowering salt intake and increasing intake of vegetables and fruits help to reduce blood pressure as well as prevent hypokalaemia.<\/jats:p>","DOI":"10.1136\/postgradmedj-2020-139701","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T18:26:46Z","timestamp":1615314406000},"page":"477-482","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Diuretic-induced hypokalaemia: an updated review"],"prefix":"10.1093","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9388-679X","authenticated-orcid":false,"given":"Ziying","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Hong Kong , Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa Y F","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong , Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-7363","authenticated-orcid":false,"given":"Bernard M Y","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hong Kong , Hong Kong, Hong Kong"},{"name":"State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong , Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of cardiology (ESC). developed with the special contribution of the heart failure association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2023041706211037400_","volume-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics","author":"Jackson","year":"2017","edition":"13th edn"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","year":"2002","journal-title":"JAMA"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/jama.293.13.1595","article-title":"Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril","volume":"293","author":"Wright","year":"2005","journal-title":"JAMA"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra0907219","article-title":"Use of diuretics in patients with hypertension","volume":"361","author":"Ernst","year":"2009","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJM199808133390707","article-title":"Hypokalemia","volume":"339","author":"Gennari","year":"1998","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","article-title":"Update in diuretic therapy: clinical pharmacology","volume":"31","author":"Brater","year":"2011","journal-title":"Semin Nephrol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2510070602","article-title":"Pharmacokinetics of the thiazide diuretics","volume":"7","author":"Welling","year":"1986","journal-title":"Biopharm Drug Dispos"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bmj.280.6218.905","article-title":"Hypokalaemia and diuretics: an analysis of publications","volume":"280","author":"Morgan","year":"1980","journal-title":"Br Med J"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"Ii152","DOI":"10.1161\/01.HYP.7.6_Pt_2.II152","article-title":"A review of 10 years of experience with indapamide as an antihypertensive agent","volume":"7","author":"Thomas","year":"1985","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/00004872-199816110-00015","article-title":"Low-Dose antihypertensive therapy with 1.5 Mg sustained-release indapamide: results of randomised double-blind controlled studies. European Study Group","volume":"16","author":"Ambrosioni","year":"1998","journal-title":"J Hypertens"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the toric study","volume":"4","author":"Cos\u00edn","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ajh.2010.1","article-title":"Meta-Analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium","volume":"23","author":"Ernst","year":"2010","journal-title":"Am J Hypertens"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/pgmj.62.725.187","article-title":"Record linkage study of hypokalaemia in hospitalized patients","volume":"62","author":"Paice","year":"1986","journal-title":"Postgrad Med J"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1530\/EC-18-0109","article-title":"Hypokalemia: a clinical update","volume":"7","author":"Kardalas","year":"2018","journal-title":"Endocr Connect"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1001\/archinte.1989.00390120043009","article-title":"Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide","volume":"149","author":"Schnaper","year":"1989","journal-title":"Arch Intern Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.35.5.1025","article-title":"Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program","volume":"35","author":"Franse","year":"2000","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2125.2005.02531.x","article-title":"Thiazide diuretic prescription and electrolyte abnormalities in primary care","volume":"61","author":"Clayton","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.resuscitation.2005.11.002","article-title":"Potassium disorders--clinical spectrum and emergency management","volume":"70","author":"Alfonzo","year":"2006","journal-title":"Resuscitation"},{"key":"2023041706211037400_","first-page":"I217","article-title":"Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 8: advanced challenges in resuscitation: section 1: life-threatening electrolyte abnormalities. the American heart association in collaboration with the International liaison Committee on resuscitation","volume":"102","author":"Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care","year":"2000","journal-title":"Circulation"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/HYPERTENSIONAHA.111.180554","article-title":"Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"59","author":"Alderman","year":"2012","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jacc.2003.06.021","article-title":"What is the optimal serum potassium level in cardiovascular patients?","volume":"43","author":"Macdonald","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/archinte.166.20.2191","article-title":"Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"166","author":"Barzilay","year":"2006","journal-title":"Arch Intern Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: a quantitative review","volume":"48","author":"Zillich","year":"2006","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/HYPERTENSIONAHA.108.114389","article-title":"Thiazide-Induced dysglycemia: call for research from a working group from the National heart, lung, and blood Institute","volume":"52","author":"Carter","year":"2008","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.112.192542","article-title":"Effects of potassium-sparing versus thiazide diuretics on glucose tolerance: new data on an old topic","volume":"59","author":"Elliott","year":"2012","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1592\/phco.29.10.1157","article-title":"Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (pear) study","volume":"29","author":"Smith","year":"2009","journal-title":"Pharmacotherapy"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11606-020-05731-3","article-title":"Thiazide diuretic-induced change in fasting plasma glucose: a meta-analysis of randomized clinical trials","volume":"35","author":"Hall","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2125.2010.03811.x","article-title":"Sex-Related differences in hospital admissions attributed to adverse drug reactions in the Netherlands","volume":"71","author":"Rodenburg","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2125.1984.tb02488.x","article-title":"Thiazide-Induced hypokalaemia; prevalence higher in women","volume":"18","author":"Toner","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","article-title":"Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis","volume":"394","author":"Suchard","year":"2019","journal-title":"Lancet"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/jhh.2009.76","article-title":"Antihypertensive drug therapy and blood pressure control in men and women: an international perspective","volume":"24","author":"Thoenes","year":"2010","journal-title":"J Hum Hypertens"},{"key":"2023041706211037400_","first-page":"c8","article-title":"Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race","volume":"120","author":"Hayes","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2017.01.044","article-title":"Race, serum potassium, and associations with ESRD and mortality","volume":"70","author":"Chen","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.33.1.18","article-title":"Normotensive salt sensitivity: effects of race and dietary potassium","volume":"33","author":"Morris","year":"1999","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.ajkd.2012.08.036","article-title":"Effects of sodium intake and diet on racial differences in urinary potassium excretion: results from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial","volume":"61","author":"Turban","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/HYPERTENSIONAHA.120.14836","article-title":"Underutilization of treatment for black adults with apparent treatment-resistant hypertension: JHS and the REGARDS study","volume":"76","author":"Langford","year":"2020","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archinternmed.2010.362","article-title":"Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the Atherosclerosis risk in communities (ARIC) study","volume":"170","author":"Chatterjee","year":"2010","journal-title":"Arch Intern Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.mayocp.2016.05.018","article-title":"Serum potassium, mortality, and kidney outcomes in the Atherosclerosis risk in Communities study","volume":"91","author":"Chen","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2215\/CJN.01730215","article-title":"Association between serum potassium and outcomes in patients with reduced kidney function","volume":"11","author":"Luo","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1523-1755.2004.00857.x","article-title":"Racial differences in potassium disposal","volume":"66","author":"Suh","year":"2004","journal-title":"Kidney Int"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2215\/CJN.08020715","article-title":"Genetic African ancestry and markers of mineral metabolism in CKD","volume":"11","author":"Guti\u00e9rrez","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jash.2017.09.011","article-title":"Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension","volume":"11","author":"Kovesdy","year":"2017","journal-title":"J Am Soc Hypertens"},{"key":"2023041706211037400_","first-page":"104","article-title":"Short-Term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data","volume":"38","author":"Krogager","year":"2017","journal-title":"Eur Heart J"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200018100-00015","article-title":"Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 Mg versus enalapril 20 Mg: the live study","volume":"18","author":"Gosse","year":"2000","journal-title":"J Hypertens"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1472-8206.2005.00377.x","article-title":"An overview of the pharmacology and clinical efficacy of indapamide sustained release","volume":"19","author":"Sassard","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.113.02252","article-title":"Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: Preterax and Diamicron controlled evaluation (advance) trial","volume":"63","author":"Chalmers","year":"2014","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","article-title":"Head-To-Head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects","volume":"65","author":"Roush","year":"2015","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/HJH.0000000000002088","article-title":"Redefining diuretics use in hypertension: why select a thiazide-like diuretic?","volume":"37","author":"Burnier","year":"2019","journal-title":"J Hypertens"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the Everest outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jacc.2016.12.035","article-title":"Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload","volume":"69","author":"Konstam","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with Empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jchf.2020.04.008","article-title":"Effect of dapagliflozin in patients with HFrEF treated with Sacubitril\/Valsartan: the DAPA-HF trial","volume":"8","author":"Solomon","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2023041706211037400_","article-title":"Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","author":"Packer","journal-title":"Eur Heart J"},{"key":"2023041706211037400_","article-title":"Heart failure drug treatment: the fantastic four","author":"Bauersachs","journal-title":"Eur Heart J"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1002\/ehf2.13124","article-title":"Heart failure in the last year: progress and perspective","volume":"7","author":"Tomasoni","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2213-8587(15)00377-0","article-title":"Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial","volume":"4","author":"Brown","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","journal-title":"BMJ"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11606-009-1209-0","article-title":"Update in new medications for primary care","volume":"25","author":"Smetana","year":"2010","journal-title":"J Gen Intern Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjcard.2004.03.070","article-title":"A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium trial","volume":"94","author":"Bray","year":"2004","journal-title":"Am J Cardiol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"e2011122","DOI":"10.1001\/jamanetworkopen.2020.11122","article-title":"Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijid.2020.09.033","article-title":"Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: a case series of 306 Mediterranean patients","volume":"100","author":"Moreno-P","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.hrtlng.2020.06.009","article-title":"Increased mortality among hypertensive COVID-19 patients: pay a closer look on diuretics in mechanically ventilated patients","volume":"49","author":"Tsolaki","year":"2020","journal-title":"Heart Lung"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1530\/EJE-20-0338","article-title":"Endocrinology in the time of COVID-19: management of diabetes insipidus and hyponatraemia","volume":"183","author":"Christ-Crain","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamacardio.2019.0640","article-title":"Development and validation of a Deep-Learning model to screen for hyperkalemia from the electrocardiogram","volume":"4","author":"Galloway","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"e15931","DOI":"10.2196\/15931","article-title":"A Deep-Learning algorithm (ECG12Net) for detecting hypokalemia and hyperkalemia by electrocardiography: algorithm development","volume":"8","author":"Lin","year":"2020","journal-title":"JMIR Med Inform"},{"key":"2023041706211037400_","doi-asserted-by":"crossref","first-page":"e012788","DOI":"10.1161\/JAHA.119.012788","article-title":"Artificial intelligence: practical primer for clinical research in cardiovascular disease","volume":"8","author":"Kagiyama","year":"2019","journal-title":"J Am Heart Assoc"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/98\/1160\/477\/49915170\/postgradmedj-98-477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/98\/1160\/477\/49915170\/postgradmedj-98-477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T20:03:27Z","timestamp":1698005007000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/98\/1160\/477\/6958929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":85,"journal-issue":{"issue":"1160","published-online":{"date-parts":[[2021,3,9]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2020-139701","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2021,3,9]]}}}